Navigation Links
Gene Therapy May Help Reverse Parkinson's Symptoms
Date:3/17/2011

By Maureen Salamon
HealthDay Reporter

THURSDAY, March 17 (HealthDay News) -- Cutting-edge gene therapy on Parkinson's disease patients significantly improved the tremors, rigidity and other motor skill problems that are hallmarks of the illness, a small new study reports.

The phase 2 study enrolled 45 patients with moderate to advanced Parkinson's disease, with half randomly assigned to receive the gene therapy and half assigned to undergo a "sham" surgery, a mock procedure designed to mimic the experimental approach.

Of the 22 patients who were infused directly into the brain with the glutamic acid decarboxylase (GAD) gene -- which prompts the production of a chemical known as GABA that improves motor control -- half experienced "clinically meaningful improvements" of their symptoms within six months of surgery, the study authors said.

Although several open-label trials on gene therapy have shown promise in treating neurologic disease, the researchers noted that this is the first of its type to be confirmed in a follow-up randomized double-blind trial, a study in which neither the investigators nor the patients knew which patients were receiving the real or sham treatment.

"It's a completely novel therapy -- unlike anything that's currently offered," said co-investigator Dr. Andrew Feigin, an associate investigator at the Center for Neurosciences at Feinstein Institute for Medical Research in Manhasset, N.Y.

"I think we expected to see this effect, but you never know," Feigin added. "I was gratified."

The study is published online March 17 in The Lancet Neurology.

Parkinson's disease affects about one million Americans, most of them over age 50, and is the second most common neurodegenerative disease after Alzheimer's, according to the National Parkinson Foundation.

In addition to confirming results of earlier clinical trials, the treatment didn't have any serious adverse ef
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Nicotine replacement therapy is over-promoted since most ex-smokers quit unassisted
2. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
3. Longview Therapy Center, PLLC, Unveils Its Definition Of Hope
4. Short-term radiation therapy successful on breast cancer
5. ASCROs Response to NY Times Articles on Radiation Therapy Incidents
6. Children With Cerebral Palsy Benefitting From New Physical Therapy Regimen
7. DavisPTnetwork Partners with the New York Physical Therapy Association to Provide Online Continuing Education
8. Behavioral therapy improves sleep and lives of patients with pain
9. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
10. Promising therapy for relapsing multibple sclerosis
11. Split-course palliative radiotherapy confirmed as effective treatment for advanced NSCLC
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Therapy May Help Reverse Parkinson's Symptoms
(Date:5/28/2015)... (PRWEB) May 28, 2015 lifeIMAGE ... million round of financing led by Cambia Health ... company dedicated to transforming health care by creating a ... and most utilized network for exchanging medical imaging, will ... customer base, increase the breadth of its network capabilities ...
(Date:5/28/2015)... Cancer survivors who participated in the LIVESTRONG at ... and quality of life, according to research conducted by ... Ligibel, MD, senior physician in the Susan F. Smith ... findings will be presented at this year’s American ... Chicago. , The study, designed to assess ...
(Date:5/28/2015)... Ask not what your racquet can do for you ... your racquet. With the launch of their new digital campaign, ... astonishing tricks and unique skill to HEAD Pro Players and ... trick artist playfully demonstrates how to gain more control over ... but also challenges tennis enthusiasts everywhere to join the show. ...
(Date:5/28/2015)... 2015 The report “Dystonia – ... the therapeutic development for Dystonia. Dystonia is characterized ... often repetitive, movements, postures, or both. Dystonia affects ... backgrounds. The report strengthens R&D pipelines by identifying ... best-in-class products. Complete report on H1 2015 pipeline ...
(Date:5/28/2015)... UT—Dymicron, Inc., (dymicron.com) confirmed the successful completion of their ... disc replacement device. The two surgeries were performed by ... Institute of Minimally Invasive Surgery (AIMIS) in Cyprus. ... of the Dymicron devices,” said Dr. William D. Smith, ... for the University Medical Center, Las Vegas, Nevada. “The ...
Breaking Medicine News(10 mins):Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4Health News:Tennis Artist Baffles Novak Djokovic - HEAD Launches Trick Shot Campaign “Frame & Play” 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2
... that umbilical cord blood might safely preserve insulin production in ... ,The study was conducted by a team of researchers led ... ,As part of the study, researchers identified children recently ... cord blood at birth, and gave seven patients ages 2 ...
... hospitals, with African American and Hispanic patients continuing to be ... Children who die of a chronic illness are more likely ... who died two decades ago. ,However, the shifting ... caregivers and policy-makers about how to best provide care and ...
... published in the Journal of the National Cancer Institute, ... is increasing, but this finding is likely explained ... Cronin-Fenton, Ph.D., of Aarhus University Hospital in Denmark, with ... found that the increase in some early stage breast ...
... youth have the highest rate of diabetes of all racial/ethnic ... being the predominant kind of diabetes among youth. ... Health Sciences Center, Denver, presented the findings of the study ... ,Estimates of the incidence of type 1 diabetes mellitus (DM) ...
... Most children who undergo cancer treatment will develop one or ... illness and complications from its treatment, a study released Tuesday ... study of more than 1,300 childhood cancer survivors found that ... health conditions by the time they reached their mid 20s, ...
... an increased risk of jaw or facial bone deterioration ... bone lesions, elevated levels of calcium in the blood, ... have found an association between the use of intravenous ... a condition in which poor blood supply to the ...
Cached Medicine News:Health News:Children With Chronic Illness Die in Hospitals 2Health News:Whites Have Highest Risk of Diabetes in U.S 2Health News:Childhood Cancer can Lead to Chronic Health Problems Later in Life: Study 2Health News:Bisphosphonate Increases the Risk of Jaw Bone Deterioration 2
(Date:5/28/2015)... 28, 2015 Cypher Genomics, Inc., ... Special Children today announced a collaboration in which Cypher,s ... diagnosis of rare genetic diseases among a unique population. ... Clinic for Special Children (CSC) serves many Amish and ... incidence of genetic disease. "We are ...
(Date:5/28/2015)... 28, 2015  Freedom Meditech, Inc., a medical device ... from current blood-based standards to early and non-invasive detection, ... in a Series C financing. The company seeks to ... since founded. The company has also appointed Mr. ... member of the company,s board of directors. Mr. Gerace ...
(Date:5/28/2015)... , May 28, 2015  Trovagene, Inc., ... molecular diagnostics, announced today the launch of its ... its Precision Cancer Monitoring SM (PCM) service ... Meeting. The campaign will center on Trovagene,s Clinical ... hands on clinical experience with the Company,s proprietary ...
Breaking Medicine Technology:Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 2Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 4Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 2Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 3Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 4
... - Millennium on track to file sNDA in ... 18 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... large, international Phase III VISTA(1) trial in,patients with ... of,VELCADE, melphalan and prednisone (VMP) demonstrated a highly ...
... 10 minutes - - Landmark Study Reported in ... 18 A landmark publication that,appeared in the Journal ... site blinded clinical study. The paper is entitled "The ... Accuracy of,Melanoma and Equivocal Melanocytic Lesions." The study, ...
Cached Medicine Technology:Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 2Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 3Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 4Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 5Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 6Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 2Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 3
Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....
Curved shafts with 0.5 mm, 1 x 2 teeth. Serrated handle with thumb catch lock and polished finish....
Jaws with fine teeth. Serrated handle with polished finish. Jaws: Wide, 4.5 mm. With thumb catch lock....
Straight shafts with curved 1 x 2 teeth. Serrated handle with polished finish....
Medicine Products: